TLR2 and neoplasm: To determine whether Tlr2 and Tlr4 signaling is required for tumor progression, we monitored tumor incidence and growth up to 19 days following B16 F1 injection in WT, Tlr2–/–, Tlr4–/–, and DKO mice.